Correction
Correction for: LncRNA AK045171 protects the heart from cardiac hypertrophy by regulating the SP1/MG53 signalling pathway. Under Investigation
- 1 Heart Center and Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China
Received: March 11, 2020 Accepted: March 21, 2020 Published: April 3, 2020
https://doi.org/10.18632/aging.102975How to Cite
Correction for:
Aging (Albany NY). 2020;
12:3126-3139
.
https://doi.org/10.18632/aging.102668
PMID: 32087602
Copyright: © 2021 Xu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article has been corrected: The authors requested the replacement of Figure 5. Figure 1A - HE staining – was placed in Figure 5C by mistake. The authors revised Figure 5.
This correction does not change the content of the publication and do not affect the conclusion of this research.
The corrected Figure 5 is provided below.
Figure 5. MG53 knockdown reversed the effect of AK045171 on cardiac hypertrophy. (C) HE staining.